Alao, Lanie C.

HRN: 28-65-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
03/03/2026
03/04/2026
IV
20 Mg
OD
Thickly MSAF, Transient Uterine Atony
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: